NCT02350985View on ClinicalTrials.gov

Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Vestibular Migraine
Interventions
DRUG

Propranolol

Propranolol was given in a flexible dose between 40 mg to 160 mg with an escalating fashion starting at 40 mg PO AM for one week and followed by 40 mg AM and 40 mg PM for a total dose up to 160 mg daily

DRUG

Venlafaxine

Venlafaxine treatment was followed as: 37.5 mg qhs for two weeks and followed 75 mg qhs with an escalating dose with 2 weeks periods up to 150 mg daily

Trial Locations (1)

34096

Haseki Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Haseki Training and Research Hospital

OTHER

NCT02350985 - Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine | Biotech Hunter | Biotech Hunter